Ausgabe 11/2022
Inhalt (22 Artikel)
The role of liver kinase B1 in tumor progression through regulation of lipid metabolism
Jialu Geng, Yanghe Zhang, Qingfei Meng, Hang Yan, Yishu Wang
MiRNAs in renal cell carcinoma
Jesús Miranda-Poma, Lucía Trilla-Fuertes, Elena López-Camacho, Andrea Zapater-Moros, Rocío López-Vacas, María Isabel Lumbreras-Herrera, Ana Pertejo-Fernandez, Juan Ángel Fresno-Vara, Enrique Espinosa-Arranz, Angelo Gámez-Pozo, Álvaro Pinto-Marín
AMPK’s double-faced role in advanced stages of prostate cancer
Faeze Gharibpoor, Sara Kamali Zonouzi, Sepideh Razi, Nima Rezaei
Colorectal cancer-derived exosomes and modulation KRAS signaling
Yan Hua Wan, Qi Sheng Liu, Sha Sha Wan, Ri Wei Wang
Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia
Homayon Yousefi, Daryush Purrahman, Mohammad Jamshidi, Elena Lak, Bijan Keikhaei, Mohammad-Reza Mahmoudian-Sani
Bone loss induced by cancer treatments in breast and prostate cancer patients
Santos Castañeda, Ana Casas, Aránzazu González-del-Alba, Guillermo Martínez-Díaz-Guerra, Xavier Nogués, Cristina Ojeda Thies, Óscar Torregrosa Suau, Álvaro Rodríguez-Lescure
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer
Ruth Vera, Carolina Ibarrola-de-Andrés, Jorge Adeva, Judith Pérez-Rojas, Pilar García-Alfonso, Yolanda Rodríguez-Gil, Teresa Macarulla, Teresa Serrano-Piñol, Rebeca Mondéjar, Beatriz Madrigal-Rubiales
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I. Lai
Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications
Jingtai Chen, Xiaohan Su, Qiao Tan, Hongyu Pu, Linxing Zhang, Yuqing Kang, Yunhui Tang, Xiaobo Zhao, Wei Hou, Shuangqiang Qian, Shishan Deng, Lingmi Hou, Yanchun Gao
Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush
Shan Li, Feibao Guo, Xuezhen Wang, Jiang Zeng, Jinsheng Hong
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
Jorge Aparicio, Anna C. Virgili Manrique, Jaume Capdevila, Félix Muñoz Boza, Patricia Galván, Paula Richart, Helena Oliveres, David Páez, Jorge Hernando, Sara Serrano, Ruth Vera, Xavier Hernandez-Yagüe, Rafael Álvarez Gallego, M. Carmen Riesco-Martinez, Xavier García de Albeniz, Joan Maurel
BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1
Shuming Chen, He Li, Siyu Chen, Bing Wang, Kaixiang Zhang
Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
Mercedes Camacho, Xavier León, Albert Pujol, Laura Montezuma, Miquel Quer, Jacinto García
Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis
Changchang Chen, Jian Shen, Yaoqiang Du, Xinwei Shi, Yaofang Niu, Gulei Jin, Yanxin Liu, Yongkang Shi, Jianxin Lyu, Lijun Lin
Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target
Akhilesh Krishna, Vineeta Singh, Nishtha Singh, Shraddha Singh, Sujit Kumar Mohanty, Rajender Singh, Vijay Kumar, Uma Shankar Singh, Rakesh Kumar Singh
The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules
Fang Li, Wei Sun, Lihua Liu, Zhen Meng, Jianli Su
Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway
Lei Deng, Jun Zou, Yongfeng Su, Meijian Wang, Lianwu Zhao
IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer
Xiu-Lin Zhu, Hao-Jue Wang, Xu-Ru Wang, Di Wu, Xuan Ji, Li Xu, Qi Yang, Jie-Ying Guo, Yan Rong, Ning Pan, Yun-lang Cai
Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism
Bo Xie, Ying Qiu, Juan Zhou, Dou Du, Haochuan Ma, Jiapeng Ji, Liquan Zhu, Weimin Zhang
Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancer
Jacobo Rogado, Fernando Pozo, Kevin Troulé, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Rebeca Mondejar, Olga Donnay, Anabel Ballesteros, Vilma Pacheco-Barcia, Javier Aspa, Fátima Al-Shahrour, Arantzazu Alfranca, Ramon Colomer
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients
Santos Castañeda, Ana Casas, Aránzazu González-del-Alba, Guillermo Martínez-Díaz-Guerra, Xavier Nogués, Cristina Ojeda Thies, Óscar Torregrosa Suau, Álvaro Rodríguez-Lescure
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I. Lai